GlassScriptPhysician profile
Kelli J Baker
NPI 1255880779
$2,586.62
in general payments reported to CMS, 2019-2025
43 companies · $611 in 2025
The $611 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $386 · 2022: $521 · 2023: $608 · 2024: $460 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,679.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $258.26 | 2021-2025 | Mounjaro, Zepbound, Lyumjev |
| Novo Nordisk INC | $242.08 | 2021-2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $187.91 | 2022-2025 | |
| Abbott Laboratories | $149.35 | 2021-2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $131.07 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.94 | 2021-2025 | Jardiance, Tradjenta |
| Sanofi-Aventis U.S. LLC | $114.34 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $111.45 | 2021-2025 | |
| Radius Health, INC. | $100.68 | 2023-2025 | Tymlos |
| Amgen INC. | $91.81 | 2021-2025 | Prolia, Evenity, Tepezza |
| Dexcom, INC. | $86.83 | 2021-2023 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $86.54 | 2023-2025 | Korlym |
| Insulet Corporation | $85.60 | 2021-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $58.96 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ibsa Pharma INC. | $56.65 | 2021-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.